SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL. (12th June 2019) - Verner, E.K.